Thioglycolic Acid

Thioglycolic Acid

SCHEMBL98408

O=C(O)CS.O=C(O)CS.OCCCO

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2A Q9UQM7 1/20 0.53
GPR84 Q9NQS5 1/20 0.48
FFAR1 O14842 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
FOLH1 Q04609 1/20 0.41
LMNA P02545 3/20 0.37
SLC22A6 Q4U2R8 1/20 0.37
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
OR51E2 Q9H255 2/20 0.35
TSHR P16473 2/20 0.35
NFKB1 P19838 1/20 0.35
PMP22 Q01453 1/20 0.35
ACE P12821 1/20 0.33
LDHA P00338 1/20 0.33
SRR Q9GZT4 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
ENPEP Q07075 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thioglycolic Acid SCHEMBL730003 1.00 CAMK2A (0.53) CAMK2AGPR84FFAR1FFAR4FOLH1
1,4-Butanediol SCHEMBL451336 0.93 GPR84 (0.55) CAMK2AGPR84FFAR1FFAR4FOLH1
1,4-Butanediol SCHEMBL31453278 0.93 GPR84 (0.55) CAMK2AGPR84FFAR1FFAR4FOLH1
1,4-Butanediol SCHEMBL60932 0.93 GPR84 (0.55) CAMK2AGPR84FFAR1FFAR4FOLH1
Thioglycolic Acid SCHEMBL96894 0.90 GPR84 (0.60) CAMK2AGPR84FFAR1FFAR4FOLH1
Thioglycolic Acid SCHEMBL7078844 0.90 GPR84 (0.60) CAMK2AGPR84FFAR1FFAR4FOLH1
Thioglycolic Acid SCHEMBL97046 0.90 GPR84 (0.60) CAMK2AGPR84FFAR1FFAR4FOLH1
1,6-Hexanediol SCHEMBL98428 0.90 GPR84 (0.60) CAMK2AGPR84FFAR1FFAR4FOLH1
1,5-Pentanediol SCHEMBL11585670 0.90 GPR84 (0.60) CAMK2AGPR84FFAR1FFAR4FOLH1
1,6-Hexanediol SCHEMBL11399082 0.90 GPR84 (0.60) CAMK2AGPR84FFAR1FFAR4FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113956477-B Curing composition and application thereof, and cured polymer material and preparation method and application thereof 中国石油化工股份有限公司 2023-10-13 CN claimed
EP-3158012-B1 FIRE-RESISTANT COMPOUND AND ITS UTILISATION HILTI AG (LI) 2020-02-19 EP claimed
US-10392516-B2 Fire protection composition and use thereof HILTI AKTIENGESELLSCHAFT (LI) 2019-08-27 US claimed
US-10287504-B2 Composition that forms an insulating layer and use thereof HILTI AKTIENGESELLSCHAFT (LI) 2019-05-14 US claimed
US-10000659-B2 Insulating layer-forming composition and use thereof HILTI AKTIENGESELLSCHAFT (LI) 2018-06-19 US claimed
EP-2935475-B1 INSULATING LAYER-FORMING COMPOSITION AND USE THEREOF HILTI AG (LI) 2017-07-19 EP claimed
US-20170145223-A1 Fireproof Composition and Use Thereof HILTI AKTIENGESELLSCHAFT (LI) 2017-05-25 US claimed
US-20170130066-A1 Fire Protection Composition and Use Thereof HILTI AKTIENGESELLSCHAFT (LI) 2017-05-11 US claimed
US-20150337160-A1 INSULATING LAYER-FORMING COMPOSITION AND THE USE THEREOF HILTI AKTIENGESELLSCHAFT (LI) 2015-11-26 US claimed
US-20150299578-A1 COMPOSITION THAT FORMS AN INSULATING LAYER AND USE THEREOF HILTI AKTIENGESELLSCHAFT (LI) 2015-10-22 US claimed
US-20150275031-A1 INSULATING LAYER-FORMING COMPOSITION AND USE THEREOF HILTI AKTIENGESELLSCHAFT (LI) 2015-10-01 US claimed
US-4093780-A ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID NORANDA MINES LIMITED (CA) 1978-06-06 US claimed
US-12492293-B2 Multi-component systems for preparing foamed products ARKEMA FRANCE (FR) 2025-12-09 US disclosed
EP-4424741-A1 EPOXY-THIOL-BASED REACTION MIXTURE FOR PRODUCING A FIRE PROTECTION ELEMENT, FIRE PROTECTION ELEMENT PRODUCED THEREFROM AND METHOD FOR PRODUCING A FIRE PROTECTION ELEMENT Hilti Aktiengesellschaft (LI) 2024-09-04 EP disclosed
EP-4424755-A1 THIOL-ACRYLATE-BASED REACTION MIXTURE FOR PRODUCING A FIRE PROTECTION ELEMENT, FIRE PROTECTION ELEMENT PRODUCED THEREFROM AND METHOD FOR PRODUCING A FIRE PROTECTION ELEMENT Hilti Aktiengesellschaft (LI) 2024-09-04 EP disclosed
US-20240199770-A1 CURABLE COMPOSITION COMPRISING A PHOTOINITIATOR ARKEMA FRANCE (FR) 2024-06-20 US disclosed
US-20120041096-A1 ENERGY-RAY-CURABLE ELASTOMER COMPOSITION, MATERIAL FOR GASKET, GASKET, AND HARD DISK DEVICE BRIDGESTONE CORPORATION (JP) 2012-02-16 US disclosed
US-20110014483-A1 PRIMER COMPOSITION MITSUI CHEMICALS, INC. 2011-01-20 US disclosed
EP-2258780-A1 PRIMER COMPOSITION Mitsui Chemicals, Inc. (JP) 2010-12-08 EP disclosed
US-4093780-A ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID NORANDA MINES LIMITED (CA) 1978-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199770-A1 CURABLE COMPOSITION COMPRISING A PHOTOINITIATOR EED, CDH1, EPB41 CAMK2A 1296/4885GPR84 2112/4885FFAR1 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.